The Sage Group

THE SAGE GROUP Highlights Specialized Peripheral Artery Disease (PAD) and Critical Limb Ischemia (CLI) Consulting Services

ATLANTA, January 25, 2011 (BUSINESS WIRE)—Mary L. Yost, President of THE SAGE GROUP, announced the launch of the company’s updated website featuring specialized consulting services. The new consulting menu highlights consulting expertise by topic as well as by geography and THE SAGE GROUP’S proprietary research databases, as well as pricing information and sample projects. For additional consulting information:

“Because we focus exclusively on peripheral artery disease, The SAGE Group represents the complete ‘one-stop’ resource for companies seeking information on atherosclerotic lower limb disease,” Ms. Yost stated.

THE SAGE GROUP has data on all stages of disease severity from asymptomatic disease to intermittent claudication and critical limb ischemia. Research includes underlying causes, comorbidities, demographics, consequences and economics as well as the entire range of diagnostic and therapeutic solutions and company participants.

“Conducting our own independent research has enabled us to develop a number of proprietary databases, which we can utilize for client-specific projects. This reduces the number of consulting hours and therefore total project costs,” declared Yost. “For example, using our population-based CLI projections we recently completed an extensive analysis of critical limb ischemia by Rutherford Category and by treatment pathway for each category for the U.S., as well as the major European markets for the 2010-2030 periods,” she elaborated.

According to Yost, “One of the reasons we added a specific section on pricing to the consulting menu was that we wanted to address the affordability issue upfront.” “Even the largest companies have budget limitations for outside research projects,” she continued.

“Sample projects are another new feature on the web site,” Ms. Yost added. “We wanted to indicate that we can do very small, immediate-turnaround projects as well as large elaborate ones. In a number of cases, we have been asked to find disease statistics for specific countries or to verify procedure statistics within a 2-3 hour timeframe,” Yost elaborated.


THE SAGE GROUP is the leading independent research and consulting company, specializing in atherosclerotic disease in the lower limbs, specifically PAD (Peripheral Artery Disease), CLI (Critical Limb Ischemia) and ALI (Acute Limb Ischemia). The most recent research focuses on PAD and ischemic diabetic foot ulcers (DFU).

For additional information visit


Mary Yost, 404-520-6652